To treat AMD, intravitreal injections are administered monthly (e.g., ranibizumab [3]), bimonthly (e.g., aflibercept [4]), or as needed, depending on the anti-VEGF agent, pathology, and progression of the condition. Here, VEGFA is linked to age-related macular degeneration.